Improving the management of head and neck cancersNovember 22, 2004Cancers of the head and neck cause over 2,700 deaths per year in England and Wales. Smoking and drinking cause most cancers of the mouth, lip and tongue (oral cavity), throat and voice box. Heavy drinkers who are also heavy smokers have over 35 times the risk of developing oral cancer than non-smokers and drinkers. Early detection and appropriate treatment improve survival, however there are variations in performance across the UK. Effective Health Care summarises the research evidence behind new guidance issued today on the management of head and neck cancers. The evidence shows that: ·Patients whose cancers are detected earlier and who are managed by multidisciplinary teams experience better outcomes. Dentists may detect oral cancer and therefore regular check-ups are important. ·Arrangements for referral at each stage of the patient's cancer journey should be streamlined. Diagnostic clinics should be established for patients with neck lumps. ·Research in this area is generally inadequate. Further research using appropriate methods is urgently required. Ros Collins, one of the authors of the research, states, 'Most head and neck cancers are preventable and better outcomes could be achieved when managing the cases that do arise. We hope that the research we have undertaken leads to real improvements in the treatment of patients suffering from these diseases.' Further information about this issue of Effective Health Care can be obtained from Rachel Richardson or Paul Wilson, Tel: 01904 321040, Fax 01904 321041. Centre for Reviews and Dissemination-CRD |
|||||||||||||||||||||
| Related Cancer Current Events and Cancer News Articles Approved lymphoma drug shows promise in early tests against bone cancer A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today in the International Journal of Cancer. Does prostate-specific antigen velocity help in early detection prostate cancer? The November issue of European Urology, the official journal of the European Association of Urology, features an article focussing on prostate specific antigen (PSA) velocity and early cancer detection. It has been suggested that changes in PSA over time aid prostate cancer detection. Key player identified in cascade that leads to hypertension-related kidney damage A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney damage has been identified by researchers who say the finding may lead to better ways to control both. First use of antibody and stem cell transplantation to successfully treat advanced leukemia For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options. New Notre Dame study provides insights into the molecular basis of tumor cell behavior A new study by a team of researchers led by Crislyn D'Souza-Schorey, associate professor of biological sciences at the University of Notre Dame, sheds light on the molecular basis by which tumor cells modulate their surroundings to favor cancer progression. Researcher: 'Optical biopsy' for breast cancer increasingly accurate But women may not have to endure the medical costs, stress and potential complications that accompany such invasive biopsies forever. A University of Florida biomedical engineering researcher is making progress on an "optical biopsy" that has the potential to determine whether growths are cancerous without ever puncturing the skin. Plastic surgeons offer microsurgery technique for breast reconstruction, tummy tuck after mastectomy Since her teens, Jennifer Jablon had watched family members deal with breast cancer during their 40s, 50s, and 60s. She wondered whether it would be her fate too. Newly revised guidelines for managing thyroid cancer published in Thyroid journal The American Thyroid Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer. New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases. Magnetic nanoparticles to simultaneously diagnose, monitor and treat Whether it's magnetic nanoparticles (mNPs) giving an army of 'therapeutically armed' white blood cells direction to invade a deadly tumour's territory, or the use of mNPs to target specific nerve channels and induce nerve-led behaviour (such as the life-dependant thumping of our hearts), mNPs have come a long way in the past decade. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||